Annals of Health Law
Volume 25
Issue 2 Summer 2016

Article 1

2016

Table of Contents
Annals of Health Law

Follow this and additional works at: https://lawecommons.luc.edu/annals
Part of the Health Law and Policy Commons

Recommended Citation
Table of Contents, 25 Annals Health L. (2016).
Available at: https://lawecommons.luc.edu/annals/vol25/iss2/1

This Prefatory Matter is brought to you for free and open access by LAW eCommons. It has been accepted for
inclusion in Annals of Health Law by an authorized editor of LAW eCommons. For more information, please contact
law-library@luc.edu.

: Table of Contents

ANNALS OF HEALTH LAW
THE HEALTH POLICY AND LAW REVIEW OF
LOYOLA UNIVERSITY CHICAGO SCHOOL OF LAW

Beazley Institute for Health Law and Policy

VOLUME 25, ISSUE 2

SUMMER 2016

CONTENTS
Foreword

...........................................

............ i

ARTICLES

Speculating A bout the Impact of H ealthcare Industry Consolidation on Long-Term
Services and Supports
Marshall B. Kapp..............................................1

The current health industry consolidation movement pronises to exert an important and
powerful array of effects on numerous different population groups seeking or receiving
health services in a variety of different health care settings. Particularly regarding the
potential impact of health industry consolidation on individuals contemplating, seeking,
or obtaining long-termservices and supports (LTSS), little is yet known but much my be
plausibly speculated. This articlejoins in that speculation, but attempts to advance the
constructive consideration of the topic by offering some suggestions for a research
agenda to investigate specific empirical questions about consolidation-s impact on LTSS
and thereby generate evidence and knowledge that can be used to either reduce or
prevent negative aspects of consolidation for LTSS, on one hand, or foster and facilitate
the achievement of positive effects, on the other.
A Profile of Bio-pharma Consolidation Activity
J ordan Paradise................

...................

................ 34

This article explores trends in bio-pharmaceutical consolidation by reviewing select
Federal Trade Comnission (FTC) actions and characterizing the features and outcomes
of the resulting mergers and acquisitions. The article first briefly discusses several
underlying drivers for bio-pharraceutical consolidation identified in the literature, as well
as the associated impacts. It utilizes the real-tim drug pricing controversies as examples
of the impact on cost associated with bio-pharn acquisitions. Next, the article explains
the FTC -s role in pre-rrerger assessments and the basic requirements on industry imposed
by federal legislation and FTC policy. The article then offers review and analysis of over
fifty FTC actions involving mergers and acquisitions in the bio-pharaceutical realm
drawing fromthree FTC publications. It characterizes core requirements and conditions
set forth in the consent orders, and synthesizes the legal landscape gleaned fromthe FTC
publications. The article then discusses implications for the future.
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Liability for Mobile Health and Wearable Technologies
Nicolas P. Terry & Lindsay F. Wiley...........................62
Most of the legal commntary regarding mobile health has focused on direct regulation
leveraging existing laws and regulators such as HIPAA privacy through the Office for
Civil Rights at the U.S. Department of Health & H unmn Services (OC R) or device
regulation by the Food and Drug Adninistration (FDA). However, much of the mobile
health revolution likely will play out in lightly regulated spaces bereft of most of the
privacy, security, and safety rules associated with traditional health care. This article
exanines the potential for cormon law liability models to bridge these gaps (even on a
temporary basis). The article provides an introduction to the terninology used, and
presents a brief typology of the apps appearing in the health care space. It discusses the
potential liability of physicians and other health care professionals and the potential
liability of institutional health care providers. The article further exai nes the
applicability of product liability to mobile health developers and vendors and explains
some of the issues that my arise when patients or consumers seek danges following
privacy or security breaches. The survey concludes by noting that regulation by litigation
my be a significant force in the app and wearable space during a period of light
regulation by traditional regulators. This is a conclusion that is unlikely to cheer either
health care providers or app developers given that the indeterninacy associated with
common law litigation is only exacerbated when applied to novel or emerging
technologies.
Health Insurer Merger Frenzy: How the Continued Arms RaceWill Disrupt
Traditional Market Roles
Erin E. Dine & MaryKathryn Hurd .............................

98

The current unprecedented surge of consolidation in the health care market continued
when two large health insurance company rrergers were announced in 2015. If approved,
these transactions would consolidate the health insurance market into three nin players
- threatening competition and disrupting the traditional health insurance market. Part I
exanines the merger frenzy occurring within the health care industry, including its drivers
and effects. Part II outlines the impact on consurnrrs and the market. Part III discusses
antitrust laws and their role in evaluating, and potentially liniting, proposed health
insurance mergers. Part IV proposes that the arms race between providers and insurers
to gain negotiation power will subside because through consolidation, health systems will
acquire the infrastructure, network, and risk-ranaging expertise necessary to imrplerent
a provider-owned insurance company. By articulating the advantages and disadvantages,
this Article explains the effect of a provider health system entering the health insurance
business. After the enactment of the Affordable Care Act, providers are taking on more
financial risk for their patients under the value-based reimbursement model. Through
provider-sponsored health plans, providers control prenium dollars through a patient-s
continuum of care, sparking financial and quality advantages for the health system This
Article-s proposed provider-sponsored health insurance company can reshape the industry
to better align stakeholder incentives and enable the delivery of high-quality, low-cost care
within a value-based reimrburserrent model.
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